FDA

>

Latest News

FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine
FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine

May 20th 2025

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

FDA Approves Incyte’s Zynyz as First-Line and Second-Line Treatment for Advanced Anal Cancer
FDA Approves Incyte’s Zynyz as First-Line and Second-Line Treatment for Advanced Anal Cancer

May 16th 2025

FDA Approves Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma
FDA Approves Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma

May 15th 2025

FDA Grants Accelerated Approval to AbbVie’s Emrelis for Previously Treated, Locally Advanced or Metastatic Non-Squamous NSCLC
FDA Grants Accelerated Approval to AbbVie’s Emrelis for Previously Treated, Locally Advanced or Metastatic Non-Squamous NSCLC

May 15th 2025

FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors
FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors

May 14th 2025

Video Interviews
Podcasts

More News